The Complementary Contributions of Sensory Stimulation and Social Support During Snoezelen Room Therapy on the General Physical and Emotional Health of the Elderly Population: Optimization of the Nursing Home Resources.

Sponsor
Pavel Goldstein (Other)
Overall Status
Recruiting
CT.gov ID
NCT05394389
Collaborator
(none)
100
1
3
11.9
8.4

Study Details

Study Description

Brief Summary

Over time, lifespan is extending, the population is aging, and accordingly there is a great demand for hospital beds in nursing homes, increasing attention to this population and the services they receive. Mostly, elderly population living in nursing homes suffers from dementia, Alzheimer, depression, agitation, and other diseases that require multidisciplinary treatment.

In addition to the medical and pharmacological treatments that patients receive to maintain functional medical status, there is a great need for non-pharmacological treatments, that may improve quality of life, mental well-being, and life satisfaction.

There are several treatment approaches of multisensory stimulation environment (MSSE). MSSE in the Snoezelen room therapy recognized as benefiting the patients' physical, mental, and emotional health status. In addition, there is great importance of intervention by social interaction, support, and encouragement.

However, the effect of combined intervention of MSSE in Snoezelen room therapy and social support, has not yet been sufficiently studied in elderly patients in nursing homes. These two interventions - together - are supposed to have an increased effect on physical and mental wellbeing of elderly.

Condition or Disease Intervention/Treatment Phase
  • Other: sensory stimulating therapy
  • Other: social support
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Supportive Care
Official Title:
The Complementary Contributions of Sensory Stimulation and Social Support During Snoezelen Room Therapy on the General Physical and Emotional Health of the Elderly Population: Optimization of the Nursing Home Resources.
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Jul 15, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: sensory-stimulating therapy

Other: sensory stimulating therapy
therapy session in the snoozlen room accompanied by social support.
Other Names:
  • integrative approach sensory stimulating therapy and social support
  • Active Comparator: social interaction

    Other: social support
    ten minutes of conversing.

    Experimental: combined sensory-stimulating therapy and social interaction.

    Other: sensory stimulating therapy
    therapy session in the snoozlen room accompanied by social support.
    Other Names:
  • integrative approach sensory stimulating therapy and social support
  • Other: social support
    ten minutes of conversing.

    Outcome Measures

    Primary Outcome Measures

    1. pain, patient- reported outcome, measured by a ruler from zero to 10, on the Likert scale [four weeks]

      An interval variable measured by a ruler from zero to 10, on the Likert scale, and with the help of illustrations of faces, the farther away from zero, the higher the intensity of pain.

    2. grip strength [eighteen minutes]

      A continuous quantitative variable presented in numerical values of isometric grip force from 0 to 90 kg and will be measured by Jamar hydraulic dynamometer. The hand grip strength will be measured in a hydraulic dynamometer borrowed from the university. The assessment does not involve any potential damage, a two-minute test in which the subject is required to press a device to measure grip strength.

    3. life satisfaction, patient-reported outcome. [four weeks]

      using the SWLS questionnaire before the first session and after the fourth(last) session as an estimation tool .Interval variable, showing scores ranging from 5-35, on the Likert scale, the higher the score it indicates more life satisfaction.

    4. general anxiety disorder, patient- reported outcome [four weeks]

      using the GAD questionnaire before the first session and after the fourth(last) session as an estimation tool.GAD- is an interval variable, which will be measured using the sum of the reports on the 7 statements on the Likert scale from 0 to 3, the higher the score on this questionnaire, the higher the level of anxiety among the patient. The total score range is from 0-21.

    5. blood pressure [eighteen minutes]

      Continuous quantitative variable, will be measured by a blood pressure monitor "Welch Allyn" measuring instrument\ device and quantitatively represented, this result variable will examine the quantitative change in systolic and diastolic blood pressure.

    Secondary Outcome Measures

    1. pulse(heart rate index) [eighteen minutes]

      Continuous quantitative variable, will be measured by "Welch Allyn" measuring instrument\ device.

    2. oxygen saturation [eighteen minutes]

      Continuous quantitative variable, will be measured by "Welch Allyn" measuring instrument\ device. and presents the degree of oxygen concentration in the blood.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients living in the Ahuzat Moriah nursing home\ geriatric nursing hospital in Shefar'am.
    Exclusion Criteria:
    • Patients with epilepsy and aggressive patients. *We do not limit the participation of patients whose cognitive level is very low.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ahuzat Moriah Shfraam Haifa North Israel 2020000

    Sponsors and Collaborators

    • Pavel Goldstein

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pavel Goldstein, Head of Integrative Pain Laboratory, University of Haifa
    ClinicalTrials.gov Identifier:
    NCT05394389
    Other Study ID Numbers:
    • Upshaifa
    First Posted:
    May 27, 2022
    Last Update Posted:
    May 27, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of May 27, 2022